|
PubHealth.info®
(a subsidiary of
PakMed) presents scientific information mainly
based on abstracts of articles published on a variety of public health issues/topics,
particularly encompassing
population planning, disease prevention, maternal and child health,
and communicable and
non-communicable diseases (like HIV AIDS, malaria, etc) that are
affecting a significant portion of population in developing and
developed
countries. Here you can find abstracts of articles published on a variety of public health
topics under category "Contraception
(Birth Control) and Family Planning".
Contraception (birth control)
is a regimen of one or more actions, devices, or medications followed in
order to deliberately prevent or reduce the likelihood of a woman
becoming pregnant or giving birth. Therefore contraception is the
utilization of various and sundry surgical procedures, devices,
practices, agents, or drugs with the intention of preventing conception
or impregnation (pregnancy). Methods and intentions typically termed
birth control may be considered a pivotal ingredient to family
planning. Birth control is a controversial political and ethical
issue in many cultures and religions, and although it is generally less
controversial than abortion specifically. |
|
|
| CATEGORY: |
Contraception (Birth Control) and Family Planning |
| Effect of oral contraceptives on thrombocyte function. |
| In: Hasegawa, T., Hayashi, M., Ebling, F.J.G., and Henderson, I.W., eds. Fertility |
| and sterility. Proceedings of the Seventh World Congress, October 17-25, 1971. |
| Tokyo and Kyoto, Japan. Amsterdam, Excerpta Medica, 1973. p. 873-874. 1 ref |
| 186 oral contraceptive cycles were investigated to study differing doses of estrogen and progesterone on platelet |
| count and function. 31 women who had never before taken oral contraceptives (aged 18-30 years) were given 2 |
| examinations during the estrogen and progestagen phases of the menstrual cycle. Then 18 were given Neogynon, |
| .25 mg norgestrel + .05 mg ethinyl estradiol, and 13 were given Noracyclin-22, 2.5 mg ethinylestrenol and .075 mg |
| mestranol. In both groups the platelet count in platelet-rich citrate plasma after 8 minutes of rotation was found to be |
| decreased after 5 and 6 months of medication. The Neogynon group had increased incidence of the nonspread |
| platelets after 4, 5, and 6 months of treatment. In both groups the coagulation-induced method of Breddin found |
| platelet aggregation significantly increased. Results were almost identical in both the high- and low-dose groups, |
| indicating that the increased platelet aggregation does not seem to be dose-dependent. Thromboelastographic |
| measurements showed no statistically significant alterations. (PubHealth.info Document ID: CONT8T 582-06) |
| PubHealth.info NOTE: The author(s) of this article titled, "Effect of oral contraceptives on thrombocyte function.", |
| is(are) Mettler L. The source of this article is "In: Hasegawa, T., Hayashi, M., Ebling, F.J.G., and Henderson, I.W., |
| eds. Fertility and sterility. Proceedings of the Seventh World Congress, October 17-25, 1971. Tokyo and Kyoto, |
| Japan. Amsterdam, Excerpta Medica, 1973. p. 873-874. 1 ref". This article was published in 1973 in English |
| language(s). (PubHealth.info® Document ID: CONT8T 582-06. All rights reserved with PubHealth.info) PIN: 35582 |
|
|
|
© Copyrights PubHealth.info®,
an information portal on public health. All rights
reserved.
This page is optimized to be viewed by
Java script enabled Microsoft®
Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels. |
